WESTBOROUGH, Mass.--(BUSINESS WIRE)--GenomeQuest, Inc., a leader in sequence search for research and IP, today announced that it is providing its flagship GenomeQuest™ solution to MIGENIX, Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases.
